Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0787 per EA under NDC 68382035305. Its NADAC has been published 389 times since Mar 13, 2019.
FDA first approved this application on Jan 17, 2014. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382035305
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201567FDA Approved
1/17/2014
TE Code
AB3
On Market Since
8/2/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 389 times since Mar 13, 2019, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per EA |
|---|---|
| All-time high | $0.3117 (Aug 14, 2019) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1015 |
| 52-week low | $0.0770 |
| Median price | $0.1137 |
| Average price | $0.1402 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 389 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0787 per EA (NDC 68382035305), effective Aug 19, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 73.2%. It has been tracked across 389 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Mar 13, 2019, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.3117 (Aug 14, 2019), with a median of $0.1137 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 68382035305) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.